EcoDrugPlus

Amine Oxidase Copper Containing 1

Ensembl ID : ENSMMDG00005013421
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSMMDG00005024376
Gene Symbol: AOC2
1 Cross references
404 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSMMDG00005024377
Gene Symbol: AOC2
1 Cross references
404 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMMDG00005021851
Gene Symbol: APP
1 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSMMDG00005009898
Gene Symbol: LOC115380474
3 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSMMDG00005008721
Gene Symbol: AR
1 Cross references
213 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSMMDG00005005468
Gene Symbol: LOC115366223
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSMMDG00005014819
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSMMDG00005011600
Gene Symbol: APLNR2
1 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSMMDG00005002738
Gene Symbol: APH1A
3 Cross references
191 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSMMDG00005008303
Gene Symbol: ALOX5
3 Cross references
225 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSMMDG00005006441
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).